Beta Bionics Balance Sheet (2023-2025) | BBNX

Balance Sheet Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 26.57M22.07M13.03M17.48M30.43M42.45M35.08M38.48M
Short-term Investments 70.18M73.14M189.02M214.65M190.20M
Cash & Current Investments 96.75M22.07M13.03M17.48M103.58M231.47M249.72M228.69M
Receivables - Net 4.49M12.11M9.18M11.51M11.68M
Receivables 4.49M12.11M9.18M11.51M11.68M
Inventory 1.25M13.32M15.73M17.32M20.37M
Prepaid Assets 1.18M4.03M5.65M7.64M9.43M
Current Assets 103.62M132.92M261.92M286.07M270.03M
Non-Current Assets
Property, Plant & Equipment (Net) 2.48M4.78M5.51M6.46M7.38M
Long-Term Investments 64.00M31.15M45.33M
Other Non-Current Assets 0.12M0.10M0.10M0.10M5.05M0.15M0.14M0.18M
Non-Current Assets 6.42M16.72M76.11M43.90M60.02M
Assets 110.04M149.65M338.02M329.97M330.05M
Liabilities
Current Liabilities
Accounts Payables 1.17M2.85M3.45M3.42M4.46M
Payables 1.17M2.85M3.45M3.42M4.46M
Accumulated Expenses 8.13M15.83M10.56M13.40M17.61M
Current Leases 1.22M1.53M1.52M1.52M1.98M
Current Deferred Revenue 0.09M0.94M0.95M1.14M1.34M
Total Current Liabilities 10.61M21.15M16.49M19.49M25.39M
Non-Current Liabilities
Non-Current Deffered Revenue 0.26M1.86M2.33M2.67M2.99M
Preferred Stock Liabilities 261.71M261.71M261.71M261.71M321.37M
Operating Leases 3.00M5.73M5.45M5.17M5.71M
Other Non-Current Liabilities 37.57M44.90M0.40M1.01M1.21M
Total Non-Current Liabilities 13.86M28.73M23.87M27.33M34.08M
Total Liabilities 51.43M214.32M221.21M228.85M73.63M24.27M28.34M35.29M
Shareholder's Equity
Common Equity -203.10M-214.32M-221.21M-228.85M-245.36M313.75M301.63M294.76M
Shareholder's Equity -203.10M-214.32M-221.21M-228.85M-245.36M313.75M301.63M294.76M
Liabilities and Shareholders Equity 110.04M149.65M338.02M329.97M330.05M
Retained Earnings -229.66M-296.74M-325.39M-342.26M-356.47M
Treasury Shares 0.94M0.89M0.82M